| Date Filed | Type | Description |
| 10/04/2023 |
4
| JOHNSTON EUGENE M (CFO) has filed a Form 4 on MANGOCEUTICALS, INC.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 10/04/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/28/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/04/2023 |
4
| Hammer Amanda Elizabeth (COO) has filed a Form 4 on MANGOCEUTICALS, INC.|
Txns:
| Granted 75,000 shares
@ $0
Granted 150,000 options to buy
@ $1.1, valued at
$165k
|
|
| 05/04/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/04/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Employment Agreement dated and effective May 1, 2023, by and between Mangoceuticals, Inc. and Amanda Hammer",
"Stock Option Agreement between Mangoceuticals, Inc. and Amanda Hammer (150,000 option shares)",
"Mangoceuticals, Inc. Appoints Amanda Hammer as New Chief Operating Officer DALLAS, TX / ACCESSWIRE / May 4, 2023 / Mangoceuticals, Inc. , a company focused on developing, marketing, and selling a variety of men’ s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction drug branded “Mango,” is pleased to announce the appointment of Amanda Hammer as Chief Operating Officer . As COO, Hammer will be responsible for helping MangoRx work to scale its operations and expand its presence in the US market. Hammer will manage the day-to-day operations of MangoRx as well as oversee its eCommerce channels, marketing, web services, human resources, compliance, and communications departments. “We couldn’ t be more excited to place our futur..." |
|
| 05/02/2023 |
4
| Cohen Jacob D. (CEO) has filed a Form 4 on MANGOCEUTICALS, INC.|
Txns:
| Gifted 8,000,000 shares
@ $0
Gifted 8,000,000 shares
@ $0
Bought 275,000 shares
@ $1, valued at
$275k
|
|
| 04/18/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/21/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 03/21/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 03/21/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/21/2023 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 03/21/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/20/2023 |
3
| JOHNSTON EUGENE M (CFO) has filed a Form 3 on MANGOCEUTICALS, INC. |
| 03/20/2023 |
3
| MYERS KENNY (Director) has filed a Form 3 on MANGOCEUTICALS, INC. |
| 03/20/2023 |
3
| D'Alessio Lorraine Pamela (Director) has filed a Form 3 on MANGOCEUTICALS, INC. |
| 03/20/2023 |
3
| Cohen Jacob D. (CEO) has filed a Form 3 on MANGOCEUTICALS, INC. |
| 02/28/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 02/06/2023 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 01/26/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 01/13/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 10/11/2022 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 08/31/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |